IGC Pharma IGC Stock
IGC Pharma Price Chart
IGC Pharma IGC Financial and Trading Overview
| IGC Pharma stock price | 0.27 USD |
| Previous Close | 0.27 USD |
| Open | 0.28 USD |
| Bid | 0 USD x 20000 |
| Ask | 0 USD x 30000 |
| Day's Range | 0.27 - 0.28 USD |
| 52 Week Range | 0.24 - 0.5 USD |
| Volume | 395.9K USD |
| Avg. Volume | 1.24M USD |
| Market Cap | 26.68M USD |
| Beta (5Y Monthly) | 0.451 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.06 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.25 USD |
IGC Valuation Measures
| Enterprise Value | 27.37M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.1364708 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 24.126898 |
| Price/Book (mrq) | 4.3 |
| Enterprise Value/Revenue | 24.744 |
| Enterprise Value/EBITDA | -3.637 |
Trading Information
IGC Pharma Stock Price History
| Beta (5Y Monthly) | 0.451 |
| 52-Week Change | -12.90% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 0.5 USD |
| 52 Week Low | 0.24 USD |
| 50-Day Moving Average | 0.3 USD |
| 200-Day Moving Average | 0.32 USD |
IGC Share Statistics
| Avg. Volume (3 month) | 1.24M USD |
| Avg. Daily Volume (10-Days) | 705.1K USD |
| Shares Outstanding | 100.09M |
| Float | 90.22M |
| Short Ratio | 1.89 |
| % Held by Insiders | 9.67% |
| % Held by Institutions | 22.51% |
| Shares Short | 1.18M |
| Short % of Float | 2.04% |
| Short % of Shares Outstanding | 1.16% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | March 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -775.39% |
| Gross Margin | 46.20% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -50.31% |
| Return on Equity (ttm) | -83.34% |
Income Statement
| Revenue (ttm) | 1.11M USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | -3.89% |
| Gross Profit (ttm) | 511K USD |
| EBITDA | -7524000 USD |
| Net Income Avi to Common (ttm) | -6446000 USD |
| Diluted EPS (ttm) | -0.06 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 235K USD |
| Total Cash Per Share (mrq) | 0.002 USD |
| Total Debt (mrq) | 917K USD |
| Total Debt/Equity (mrq) | 14.98 USD |
| Current Ratio (mrq) | 1.324 |
| Book Value Per Share (mrq) | 0.062 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5544000 USD |
| Levered Free Cash Flow (ttm) | -2521375 USD |
Profile of IGC Pharma
| Country | United States |
| State | MD |
| City | Potomac |
| Address | 10224 Falls Road |
| ZIP | 20854 |
| Phone | 301 983 0998 |
| Website | https://igcpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 70 |
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.
Q&A For IGC Pharma Stock
What is a current IGC stock price?
IGC Pharma IGC stock price today per share is 0.27 USD.
How to purchase IGC Pharma stock?
You can buy IGC shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for IGC Pharma?
The stock symbol or ticker of IGC Pharma is IGC.
Which industry does the IGC Pharma company belong to?
The IGC Pharma industry is Biotechnology.
How many shares does IGC Pharma have in circulation?
The max supply of IGC Pharma shares is 100.09M.
What is IGC Pharma Price to Earnings Ratio (PE Ratio)?
IGC Pharma PE Ratio is now.
What was IGC Pharma earnings per share over the trailing 12 months (TTM)?
IGC Pharma EPS is -0.06 USD over the trailing 12 months.
Which sector does the IGC Pharma company belong to?
The IGC Pharma sector is Healthcare.